These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7923986)

  • 21. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dialysis membrane biocompatibility: effects on cellular elements.
    Coli L; De Sanctis LB; Feliciangeli G; Iannelli S; Scolari MP; Todeschini P; Tumietto F; Costigliola P; Chiodo F
    Nephrol Dial Transplant; 1995; 10 Suppl 10():27-32. PubMed ID: 8825429
    [No Abstract]   [Full Text] [Related]  

  • 23. Comment on middle molecule removal in low-flux polysulfone dialyzers: impact of flows and surface area on whole-body and dialyzer clearances.
    Polaschegg HD
    Hemodial Int; 2006 Apr; 10(2):215-6; author reply 216. PubMed ID: 16623678
    [No Abstract]   [Full Text] [Related]  

  • 24. Increased soluble CD14 levels in patients on hemodialysis. Influence of dialysate endotoxin or incompatibility to dialyzer membranes?
    Mitzner S; Stange J; Pichel K; Handschuk I; Korten G; Ehlers M; Schutt C; Schmidt R
    ASAIO J; 1995; 41(3):M707-8. PubMed ID: 8573897
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
    Muniz-Junqueira MI; Braga Lopes C; Magalhães CA; Schleicher CC; Veiga JP
    Life Sci; 2005 Nov; 77(25):3141-55. PubMed ID: 16005905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The next generation of dialysis membranes--barriers or pathways?
    Streicher E; Schneider H
    Contrib Nephrol; 1985; 44():127-36. PubMed ID: 3987283
    [No Abstract]   [Full Text] [Related]  

  • 27. Microcapsule artificial kidney: including updated preparative procedures and properties.
    Chang TM
    Kidney Int Suppl; 1976 Dec; (7):S218-24. PubMed ID: 1070536
    [No Abstract]   [Full Text] [Related]  

  • 28. One year follow-up of short dialysis with a membrane highly permeable to middle molecules.
    Man NK; Granger A; Rondon-Nucete M; Zingraff J; Jungers P; Sausse A; Funck-Brentano JL
    Proc Eur Dial Transplant Assoc; 1973; 10(0):236-46. PubMed ID: 4802554
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of two dialysers (AN69ST vs. FX100) for heparin-free dialysis in patients with oral anticoagulation.
    Kodras K; Benesch T; Neumann I; Haas M
    Blood Purif; 2008; 26(3):226-30. PubMed ID: 18305385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes.
    Krieter DH; Lemke HD; Wanner C
    Nephrol Dial Transplant; 2006 Feb; 21(2):546; author reply 546. PubMed ID: 16249195
    [No Abstract]   [Full Text] [Related]  

  • 31. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The AN69ST dialysis membrane. A new approach for reducing systemic heparinization.
    Renaux JL; Atti M
    Contrib Nephrol; 2002; (137):111-9. PubMed ID: 12101943
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute effect of haemodialysis on arterial stiffness: membrane bioincompatibility?
    Mourad A; Carney S; Gillies A; Jones B; Nanra R; Trevillian P
    Nephrol Dial Transplant; 2004 Nov; 19(11):2797-802. PubMed ID: 15340092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid abnormalities in chronic renal failure patients undergoing hemodialysis.
    de Gómez Dumm NT; Giammona AM; Touceda LA; Raimondi C
    Medicina (B Aires); 2001; 61(2):142-6. PubMed ID: 11374135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue factor, its inhibitor, and the thrombogenicity of two new synthetic membranes.
    Zemanova P; Opatrny K; Vit L; Sefrna F
    Artif Organs; 2005 Aug; 29(8):651-7. PubMed ID: 16048482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Removal of inorganic phosphate on hemodialysis].
    Ando Y; Sekiguchi H; Ando K
    Nihon Rinsho; 1991 Dec; 49 Suppl():157-61. PubMed ID: 1808248
    [No Abstract]   [Full Text] [Related]  

  • 37. [Adsorption of glucoregulatory hormones by dialysis membrane].
    Tajima N; Koga A; Kanda H; Chikugo K; Nakao T; Kouka K; Furukawa Y
    Nihon Rinsho; 1991 Dec; 49 Suppl():185-9. PubMed ID: 1808253
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of continuous implantable renal replacement: past and future.
    Fissell WH; Fleischman AJ; Humes HD; Roy S
    Transl Res; 2007 Dec; 150(6):327-36. PubMed ID: 18022594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Thermal energy balance during hemodialysis: the role of the filter membrane].
    Panzetta G; Bianco F; Galli G; Ianche M; Savoldi S; Vianello S; Vidi E; Cicinato P
    G Ital Nefrol; 2002; 19(4):425-31. PubMed ID: 12369045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo studies with a non-aluminum phosphate-binding compound.
    Schneider HW; Kulbe KD; Weber H; Streicher E
    Kidney Int Suppl; 1986 Feb; 18():S120-3. PubMed ID: 3457989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.